De Burlo Group Inc Neurocrine Biosciences Inc Transaction History

De Burlo Group Inc

  • $675 Million
  • Q1 2025

A detailed history of De Burlo Group Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, De Burlo Group Inc holds 4,717 shares of NBIX stock, worth $578,492. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,717
Previous 4,617 2.17%
Holding current value
$578,492
Previous $630,000 17.3%
% of portfolio
0.08%
Previous 0.09%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 07, 2025
BUY
$107.22 - $153.29 $10,722 - $15,329
100 Added 2.17%
4,717 $521,000
Q4 2024

Feb 14, 2025
SELL
$111.62 - $139.44 $55,810 - $69,720
-500 Reduced 9.77%
4,617 $630,000
Q2 2024

Aug 14, 2024
SELL
$130.86 - $143.19 $6,543 - $7,159
-50 Reduced 0.97%
5,117 $704,000
Q1 2024

May 13, 2024
SELL
$130.4 - $143.74 $521,600 - $574,960
-4,000 Reduced 43.63%
5,167 $712,000
Q3 2022

Nov 14, 2022
BUY
$92.03 - $107.81 $843,639 - $988,294
9,167 New
9,167 $973,000
Q2 2022

Aug 11, 2022
SELL
$75.79 - $100.07 $707,348 - $933,953
-9,333 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$72.45 - $94.81 $105,052 - $137,474
-1,450 Reduced 13.45%
9,333 $874,000
Q4 2021

Jan 28, 2022
SELL
$79.65 - $106.22 $55,755 - $74,354
-700 Reduced 6.1%
10,783 $918,000
Q1 2021

May 06, 2021
SELL
$87.57 - $119.4 $8,757 - $11,940
-100 Reduced 0.86%
11,483 $1.12 Million
Q4 2020

Feb 05, 2021
SELL
$86.91 - $108.33 $26,073 - $32,499
-300 Reduced 2.52%
11,583 $1.11 Million
Q3 2020

Nov 05, 2020
BUY
$96.16 - $135.15 $12,789 - $17,974
133 Added 1.13%
11,883 $1.14 Million
Q1 2020

May 07, 2020
SELL
$75.11 - $113.76 $22,533 - $34,128
-300 Reduced 2.49%
11,750 $1.02 Million
Q4 2019

Feb 06, 2020
SELL
$86.8 - $118.57 $26,040 - $35,571
-300 Reduced 2.43%
12,050 $1.3 Million
Q2 2019

Aug 07, 2019
SELL
$72.24 - $91.27 $21,672 - $27,381
-300 Reduced 2.37%
12,350 $1.04 Million
Q1 2019

May 09, 2019
SELL
$69.31 - $91.53 $252,981 - $334,084
-3,650 Reduced 22.39%
12,650 $1.11 Million
Q4 2018

Feb 07, 2019
SELL
$68.32 - $124.36 $40,991 - $74,616
-600 Reduced 3.55%
16,300 $1.16 Million
Q4 2017

Feb 08, 2018
SELL
$58.53 - $77.59 $46,824 - $62,072
-800 Reduced 4.52%
16,900 $1.31 Million
Q3 2017

Nov 02, 2017
BUY
$47.97 - $61.28 $849,069 - $1.08 Million
17,700
17,700 $1.08 Million

Others Institutions Holding NBIX

# of Institutions
650
Shares Held
97.2M
Call Options Held
749K
Put Options Held
553K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.7B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track De Burlo Group Inc Portfolio

Follow De Burlo Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of De Burlo Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on De Burlo Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email